Analysts Offer Insights on Financial Companies: Community Healthcare (CHCT), Ocwen Financial (OCN) and Douglas Elliman Inc. (DOUG)

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Community Healthcare (CHCT – Research Report), Ocwen Financial (OCN – Research Report) and Douglas Elliman Inc. (DOUG – Research Report).

Community Healthcare (CHCT)

Colliers Securities analyst David Toti reiterated a Hold rating on Community Healthcare today and set a price target of $42.00. The company’s shares closed last Friday at $35.29.

According to TipRanks.com, Toti is a 1-star analyst with an average return of -5.1% and a 43.5% success rate. Toti covers the Financial sector, focusing on stocks such as National Retail Properties, NexPoint Residential, and Medical Properties.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Community Healthcare with a $42.00 average price target.

See today’s best-performing stocks on TipRanks >>

Ocwen Financial (OCN)

Jefferies analyst Kyle Joseph maintained a Buy rating on Ocwen Financial on November 4 and set a price target of $44.00. The company’s shares closed last Friday at $37.05.

According to TipRanks.com, Joseph is a 4-star analyst with an average return of 10.7% and a 57.0% success rate. Joseph covers the Financial sector, focusing on stocks such as Oaktree Specialty Lending, Pennantpark Investment, and Gladstone Investment.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Ocwen Financial with a $37.00 average price target.

Douglas Elliman Inc. (DOUG)

In a report released today, Daniel Fannon from Jefferies maintained a Buy rating on Douglas Elliman Inc., with a price target of $6.00. The company’s shares closed last Friday at $4.08, close to its 52-week low of $3.83.

According to TipRanks.com, Fannon is a 5-star analyst with an average return of 10.0% and a 66.4% success rate. Fannon covers the Financial sector, focusing on stocks such as Janus Henderson Group, Goldman Sachs Group, and Interactive Brokers.

Currently, the analyst consensus on Douglas Elliman Inc. is a Moderate Buy with an average price target of $6.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on CHCT:

• Genasys Inc. Schedules Fiscal Year 2022 Financial Results and Conference Call for November 30, 2022
• Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Andrea DiFabio as Chief Legal Officer and Corporate Secretary
• TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Third Quarter 2022 Financial Results on Thursday, November 10, 2022
• Reliance Global Group Schedules Third Quarter 2022 Financial Results and Business Update Conference Call
• ABVC BioPharma Receives Notice of Allowance from US Patent and Trademark Office for ABV-1504 Used to Treat Major Depressive Disorder (MDD)